Lapatinib is a crucial drug used to treat breast cancer, specifically HER2-positive cases. This life-saving medication is manufactured by several leading pharmaceutical companies committed to quality and innovation.
Lapatinib manufacturer include GlaxoSmithKline (GSK), the original developer, and other global pharmaceutical firms that produce generic versions. These companies follow strict regulatory guidelines to ensure safety, efficacy, and affordability.